Site Members can sign up for company wide alerts
Investigation Overview
February 11, 2014 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Cadence Pharmaceuticals, Inc. (NASDAQ:CADX) shares, was announced concerning whether the takeover of Cadence Pharmaceuticals, Inc. by Mallinckrodt plc for $14.00 per share is unfair to NASDAQ:CADX stockholders. The investigation by a law firm concerns whether certain off...
You must register (for free) or login to view the entire investigation.